To Evaluate Reduction of Pain in Wounds Treatment Previously Applying Lidocaine Topical Solution vs Placebo.

• Status: Recruiting
• Trial end date: 2021-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate if applying a lidocaine topical solution before wounds treatment decreases the pain of the procedure in comparison with placebo solution.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital Universitari de Bellvitge
• Treatments: Lidocaine; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Patient who has accepted and signed the informed consent before the random process.

• Women or men aged more than 18 years

• Patients with painful wound treatments (> or = 5) who come to outgoing area for the treatment

• Wounds or sores of any aetiology sauf arterial deficit that implies at minimum dermis or epidermis, it is, II to IV degree in the Spanish Classification of Sores made by the "National Group to Study and Management of Pressure Ulcers and Chronic Wounds" (GNEAUPP).

• Women in fertile age with pregnancy test negative

Exclusion Criteria:

• Precedents of allergic reaction to local anesthesics type amides.

• Wounds or sores degree I on the GNEAUPP Classification (it is, without discontinuity of skin).

• Wounds or sores too large (which requirej more than 40 ml of solution to cover)

• Wounds around the eyes

• Wounds secondary to arterial deficit

• Patients who presents disturbance of cardiac conduction: atrioventricular block (second or third degree) or bifascicular block

• Patients with altered level of consciousness (Glasgow Coma Scale value less than 14)

• Patients following hemodialysis, peritoneal dialysis or continuous hemofiltration treatment

• Patients suffering moderate or severe hepatic insufficiency

• Pregnant or lactating women

• Once the patient has already participate in the study during a previous wound treatment

• Patients who refuse to participate in the study